US SEC Trading Suspension Halt Orders — May 27, 2026

USA Trading Suspensions

By Gunpowder Editorial ·

5 high priority 5 total filings analysed

Executive Summary

The five filings for May 27, 2026, reveal a severe cluster of Nasdaq non-compliance events, with all five companies receiving deficiency notices for late filings, low market values, or insufficient equity. This concentration of regulatory risk suggests a broader market trend of small-cap distress, likely driven by tight financing conditions and operational challenges.

Period-over-period comparisons are not directly available for these specific filings, but the recurrence of late filings (Borealis, Greenwave) and the failure to regain compliance after initial notices (Liminatus, SOBR Safe) indicate deteriorating financial controls and liquidity. The most critical development is the potential delisting of Liminatus Pharma, which has exhausted its compliance period and is now in a high-stakes appeal. The market implications are significant: investors face heightened delisting risk, potential trading halts, and severe share price volatility across these names. The portfolio-level pattern is a clear 'delisting wave' in the micro-cap space, with no bullish signals and a uniform negative sentiment across all filings.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from May 26, 2026.

Investment Signals (8)

  • Received a second Nasdaq deficiency notice for late Q1 2026 filing, compounding prior late 10-K; has until June 16 to submit compliance plan; expects to file by early June, but any delay risks delisting.

  • Failed to regain compliance with $50M MVLS and $15M MVPHS rules after 180-day period; delisting notice received May 20; appeal filed May 26 provides only a temporary stay.

  • Second delinquency notice for late Q1 2026 filing, adding to prior late 10-K; compliance plan deadline June 22; exception period until Oct 12, 2026, if accepted.

  • SOBR Safe (BEARISH)

    Bid price deficiency persists after cumulative reverse splits (1-for-1100) exceeding Nasdaq threshold; continued listing contingent on completing a business combination with Clean World Ventures by Sept 15, 2026.

  • Stockholders' equity of ~$904,000 falls far below the $2.5M minimum; 45 days to submit compliance plan; no alternative compliance pathways available.

  • All Five Companies (BEARISH)

    Zero insider buying activity reported in any filing, indicating a lack of management confidence in near-term recovery.

  • All Five Companies (BEARISH)

    No forward-looking guidance or revenue forecasts provided, signaling extreme uncertainty about future operations.

  • All Five Companies (BEARISH)

    No capital allocation actions (dividends, buybacks) reported, consistent with distressed financial positions.

Risk Flags (7)

  • The appeal stay is temporary; if the Nasdaq Hearings Panel denies the request, trading will be suspended immediately, leading to a total loss of liquidity for shareholders.

  • The continued listing is contingent on closing a deal with Clean World Ventures; any failure to complete the merger by Sept 15, 2026, will trigger delisting.

  • Two consecutive late filings (10-K and 10-Q) indicate systemic internal control failures, increasing the likelihood of future non-compliance.

  • The company must cure both the late 10-K and late 10-Q simultaneously; any delay in filing the Q1 10-Q will leave both deficiencies unresolved.

  • With only $904k in equity vs. $2.5M required, the company faces a 64% deficit; financing efforts may be dilutive or unsuccessful.

  • All Five Companies/No Insider Buying [HIGH RISK]

    The complete absence of insider purchases across all five filings is a strong signal that management does not see value in their own stock at current levels.

  • All Five Companies/Liquidity Risk [MEDIUM RISK]

    None of the companies reported any capital allocation (dividends, buybacks), suggesting they are conserving cash to survive, not to reward shareholders.

Opportunities (6)

  • If the company files its Q1 10-Q by early June as expected, it could cure both deficiencies and remove the delisting risk, potentially triggering a short-term rally.

  • The potential exception until Oct 12, 2026, provides a runway for the company to file and regain compliance; a successful filing could alleviate selling pressure.

  • The business combination with Clean World Ventures could create value if completed; monitoring deal progress and regulatory approvals could yield a high-risk, high-reward trade.

  • If the company secures financing to boost equity above $2.5M, the stock could re-rate as delisting fears subside; the 45-day plan submission deadline is a key catalyst.

  • A favorable ruling from the Nasdaq Hearings Panel could grant an extension, providing a temporary reprieve and potential for a short squeeze.

  • All Five Companies/Short Squeeze Potential (OPPORTUNITY)

    Given the negative sentiment and potential for sudden positive news (e.g., compliance plans accepted), these stocks could experience sharp short-term rallies.

Sector Themes (5)

  • Micro-Cap Delisting Wave

    5 out of 5 filings in this stream involve Nasdaq non-compliance, indicating a concentrated wave of distress among small-cap companies struggling with reporting and financial standards. [IMPLICATION: Investors should avoid micro-cap names with weak balance sheets and late filings.]

  • Recurring Filing Failures

    2 out of 5 companies (Borealis, Greenwave) received multiple delinquency notices for late 10-K and 10-Q filings, suggesting systemic internal control weaknesses rather than isolated events. [IMPLICATION: Companies with one late filing are at high risk of additional failures.]

  • No Capital Returns

    0 out of 5 companies reported any dividends, buybacks, or capital allocation actions, underscoring a sector-wide cash conservation mode. [IMPLICATION: Shareholder returns are non-existent in this segment; focus on survival.]

  • Absence of Insider Confidence

    0 out of 5 filings reported any insider buying, while the uniform negative sentiment suggests management is not backing the stock. [IMPLICATION: Insider activity is a critical signal; its absence here confirms bearish outlook.]

  • Dependency on External Events

    2 out of 5 companies (SOBR Safe, Sintx) have their listing status contingent on external events (merger, financing), adding binary risk. [IMPLICATION: These are not investment-grade situations; only for high-risk speculators.]

Watch List (7)

  • Expected by early June 2026; if filed, could cure both deficiencies and remove delisting risk. [Date: Early June 2026]

  • Deadline June 22, 2026; acceptance by Nasdaq will determine if the company gets an exception until Oct 12, 2026. [Date: June 22, 2026]

  • The appeal stay is temporary; the panel's ruling will determine if the stock remains listed or is suspended. [Date: TBD, likely within weeks]

  • Must complete merger with Clean World Ventures by Sept 15, 2026; any delays will trigger delisting. [Date: Sept 15, 2026]

  • 45-day deadline from May 22, 2026, falls around July 6, 2026; plan acceptance is critical. [Date: ~July 6, 2026]

  • All Five Companies/Insider Trading Activity
    👁

    Monitor for any insider buying or selling in the coming weeks; a sudden insider purchase would be a strong bullish signal. [Date: Ongoing]

  • All Five Companies/Subsequent 8-K Filings
    👁

    Watch for any updates on compliance plans, financing, or merger progress; these will be key catalysts. [Date: Ongoing]

Filing Analyses (5)
Borealis Foods Inc. 8-K negative materiality 8/10

27-05-2026

Borealis Foods Inc. received a Nasdaq deficiency notice on May 21, 2026, for failing to timely file its Q1 2026 Form 10-Q, supplementing a prior notice for its delayed 2025 Form 10-K. The company has until June 16, 2026, to submit a compliance plan and expects to file the Q1 10-Q by early June 2026, which it believes will cure both deficiencies. However, if the plan is not accepted or the filings are further delayed, the company faces potential delisting from the Nasdaq Capital Market.

  • · The Nasdaq notice has no immediate effect on the listing or trading of the Company's Common Shares (BRLS) or Warrants (BRLSW).
  • · The prior notice for the delayed 2025 Form 10-K was received on April 17, 2026.
  • · If Nasdaq accepts the compliance plan, the company may be granted up to 180 calendar days from the due date of the 2025 Form 10-K, or until October 12, 2026, to regain compliance.
  • · The company anticipates filing the Q1 2026 Form 10-Q no later than early June 2026.
Liminatus Pharma, Inc. 8-K negative materiality 9/10

27-05-2026

Liminatus Pharma, Inc. received a notice from Nasdaq on May 20, 2026, that it has failed to regain compliance with the $50M market value of listed securities (MVLS) rule and the $15M market value of publicly held shares (MVPHS) rule. The company's securities were set to be suspended and delisted from The Nasdaq Global Market, but on May 26, 2026, the company requested an appeal before the Nasdaq Hearings Panel, which stays any suspension or delisting action pending the hearing. The outcome of the appeal remains uncertain.

  • · The initial non-compliance notices from Nasdaq were received on November 19, 2025.
  • · The 180-day compliance period expired on May 18, 2026.
  • · The delisting notice was received on May 20, 2026.
  • · Without an appeal, trading suspension would begin at the opening of business on May 29, 2026.
  • · The company requested an appeal before the Nasdaq Hearings Panel on May 26, 2026, which stays any delisting action pending the hearing.
  • · The filing includes forward-looking statements and disclaimers about the uncertainty of regaining compliance.
Greenwave Technology Solutions, Inc. 8-K negative materiality 9/10

27-05-2026

Greenwave Technology Solutions, Inc. (GWAV) received a second Nasdaq delinquency notice on May 21, 2026, for failing to timely file its Q1 2026 Form 10-Q, adding to a prior notice for its late 2025 Annual Report (10-K). The company has until June 22, 2026, to submit a compliance plan; if accepted, Nasdaq may grant an exception until October 12, 2026. There is no immediate impact on trading, but the company faces significant ongoing listing risk.

  • · The latest notice (May 21, 2026) is for failure to file the Q1 2026 Form 10-Q; a prior notice (April 22, 2026) was for the 2025 Annual Report (Form 10-K).
  • · Deadline to submit a compliance plan to Nasdaq is June 22, 2026.
  • · If a plan is accepted, the exception period runs until October 12, 2026 (180 calendar days from the Annual Report due date).
  • · The company's common stock continues trading on the Nasdaq Capital Market under symbol GWAV during this process.
  • · The filing includes cautionary forward-looking statements that there is no assurance the company will ultimately comply or be granted relief.
SOBR Safe, Inc. 8-K negative materiality 9/10

27-05-2026

SOBR Safe, Inc. received a deficiency letter from Nasdaq on March 19, 2026, due to its common stock closing bid price remaining below $1.00 for 30 consecutive business days. The company also became ineligible for the standard 180-day compliance period because cumulative reverse stock splits (1-for-110 in October 2024 and 1-for-10 in April 2025, totaling 1-for-1100) exceeded the 1-for-250 threshold. After a hearing on April 28, 2026, the Nasdaq Hearings Panel granted continued listing until September 15, 2026, contingent on completing a proposed business combination with Clean World Ventures, Inc. and demonstrating compliance with Nasdaq's Initial Listing Rules.

  • · The company received the initial deficiency letter on March 19, 2026, and filed a hearing request on March 26, 2026.
  • · A stay of delisting was granted on March 30, 2026, pending the hearing.
  • · The delisting hearing was held on April 28, 2026.
  • · The Hearings Panel granted continued listing until September 15, 2026, subject to completing the business combination with Clean World Ventures, Inc. and demonstrating compliance with Nasdaq's Initial Listing Rules.
Sintx Technologies, Inc. 8-K negative materiality 9/10

27-05-2026

SINTX Technologies received a Nasdaq notice on May 22, 2026, for non-compliance with the minimum $2.5 million stockholders' equity requirement (reported equity ~$904,000). The company has 45 days to submit a compliance plan and is pursuing financing, but there is no assurance of regaining compliance.

  • · The company does not meet alternative standards: market value of listed securities at least $35M or net income from continuing operations of $500,000 in the most recent fiscal year or two of last three years.
  • · The Notice has no immediate effect on the listing or trading of the company's common stock on The Nasdaq Capital Market.

Get daily alerts with 8 investment signals, 7 risk alerts, 6 opportunities and full AI analysis of all 5 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US SEC Trading Suspension Halt Orders

🇺🇸 More from United States

View all →